ArticleJournal for immunotherapy of cancer2020

Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma.

Daan P Hurkmans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.